Keyphrases
Immune Infiltration
100%
Psychological Stress
100%
Tumor
96%
Immune System
78%
Immunosuppression
75%
Ovarian Cancer
75%
Programmed Death-ligand 1 (PD-L1)
75%
3D Co-culture Model
75%
Individual-based Model
75%
Propranolol
75%
Tumor Spheroids
75%
Tumor Immunity
75%
Immune Cells
59%
66cl4
50%
Epithelial Ovarian Cancer
46%
Cortisol
37%
Stress Hormones
37%
Metastasis
28%
PD-L1 Inhibitor
28%
Screening Tool
25%
Interleukin-10
25%
In Vitro Model
25%
Spheroid Formation
25%
In Vivo Model
25%
Glucocorticoid Receptor Antagonist
25%
Co-culture Model
25%
Confocal Image
25%
Cancer Spheroids
25%
Numerical Simulation
25%
Tumor-immune Interaction
25%
Syngeneic
25%
Treatment Effect
25%
Behavioral Stress
18%
Copyright
18%
Extracellular Vesicles
18%
Combined Therapy
18%
Growth Rate
12%
Interaction Dynamics
12%
Breast Tumor
12%
Cell Parameters
12%
Motility
12%
Stress Conditions
12%
In Vitro Experiment
12%
Biological Mechanisms
12%
Biological Stress
12%
Anti-inflammatory Cytokines
12%
Model Support
12%
Cancer Model
9%
Stress-induced
9%
IL-10 Levels
9%
Immunology and Microbiology
Coculture
85%
Immunity
85%
Programmed Death-Ligand 1
75%
Tumor Immunity
75%
Immunosuppression
75%
Immune System
69%
Tumor Spheroid
56%
Immunocompetent Cell
40%
Glucocorticoid
37%
Immunotherapy
29%
CD8
21%
Immune Cell Infiltration
18%
Mental Stress
18%
Syngenic
18%
Mouse Model
18%
Cortisol
18%
Computer Simulation
12%
Signal Transduction
10%
Cell Death
10%
Cancer Cell
10%
Cell Population
10%
T Cell
10%
Ovarian Cancer Cell Line
10%
Tumor-Associated Macrophage
10%
Immune Response
10%
Upregulation
10%
Agonist
10%
Interleukin 10
10%
Medicine and Dentistry
Immunosuppressive Treatment
75%
Programmed Death-Ligand 1
75%
Tumor Immunity
75%
Ovarian Cancer
75%
Propranolol
75%
Krukenberg Tumor
56%
Neoplasm
46%
Immune System
28%
Metastatic Carcinoma
28%
Combined Therapy
18%
Behavioral Stress
18%
Immunocompetent Cell
18%
CD8 Antigen
18%
Incubation
9%
Cancer Model
9%
Programmed Cell Death
9%
Signal Transduction
9%
Noradrenalin
9%
Immunotherapy
9%
Cancer Cell
9%
Monotherapy
9%
Tumor Infiltrating Lymphocyte
9%
Cell Population
9%
Ovarian Cancer Cell Line
9%
T-Cell Response
9%
Sympathomimetic Drug
9%
In Vitro
9%
Cancer Control
9%
Upregulation
9%
Immune Response
9%
Beta Adrenergic Receptor Blocking Agent
9%
Ex Vivo
9%
Malignant Neoplasm
9%
Interleukin 10
9%
Immunity
9%